{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:14:45Z","timestamp":1788470085127,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics & Development"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gde.2026.102511","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T19:49:28Z","timestamp":1783453768000},"page":"102511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Functional immunogenomics and deep clinical phenotyping to resolve the challenges of heterogeneity in mental disorders"],"prefix":"10.1016","volume":"100","author":[{"given":"Evelien","family":"Van Assche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard T","family":"Baune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gde.2026.102511_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biopsych.2020.09.026","article-title":"Pleiotropy and cross-disorder genetics among psychiatric disorders","volume":"89","author":"Lee","year":"2021","journal-title":"Biol Psychiatry"},{"issue":"8096","key":"10.1016\/j.gde.2026.102511_sbref2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41586-025-09820-3","article-title":"Mapping the genetic landscape across 14 psychiatric disorders","volume":"649","author":"Grotzinger","year":"2025","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.gde.2026.102511_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1176\/appi.ajp.2014.14020138","article-title":"The NIMH Research Domain Criteria (RDoC) project: precision medicine for psychiatry","volume":"171","author":"Insel","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12916-022-02414-0","article-title":"Revisiting the seven pillars of RDoC","volume":"20","author":"Morris","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.gde.2026.102511_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1037\/abn0000258","article-title":"The Hierarchical Taxonomy of Psychopathology (HiTOP): a dimensional alternative to traditional nosologies","volume":"126","author":"Kotov","year":"2017","journal-title":"J Abnorm Psychol"},{"issue":"4","key":"10.1016\/j.gde.2026.102511_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1176\/appi.ajp.2015.14091200","article-title":"Identification of distinct psychosis biotypes using brain-based biomarkers","volume":"173","author":"Clementz","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2024.100117","article-title":"Cognitive performance and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT) - 2","volume":"12","author":"Clementz","year":"2025","journal-title":"Biomark Neuropsychiatry"},{"key":"10.1016\/j.gde.2026.102511_sbref8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/s41380-024-02878-x","article-title":"Assessment and ascertainment in psychiatric molecular genetics: challenges and opportunities for cross-disorder research","volume":"30","author":"Cai","year":"2025","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.840266","article-title":"Complement dependent synaptic reorganisation during critical periods of brain development and risk for psychiatric disorder","volume":"16","author":"Westacott","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.gde.2026.102511_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41577-019-0131-x","article-title":"Cytokine-mediated communication: a quantitative appraisal of immune complexity","volume":"19","author":"Altan-Bonnet","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.gde.2026.102511_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41380-022-01891-2","article-title":"Taking subjectivity seriously: towards a unification of phenomenology, psychiatry, and neuroscience","volume":"28","author":"Kyzar","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.stemcr.2022.03.019","article-title":"Functional genomics and the future of iPSCs in disease modeling","volume":"17","author":"Brooks","year":"2022","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.gde.2026.102511_bib13","series-title":"Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5)","first-page":"991","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.gde.2026.102511_bib14","unstructured":"World Health Organization: International statistical classification of diseases and related health problems \u2013 Eleventh revision (ICD-11), 11th edn. in World Health Organization. World Health Organization; 2019. Available from: \u3008https:\/\/icd.who.int\/browse10\/2019\/en\u3009."},{"key":"10.1016\/j.gde.2026.102511_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s44159-022-00050-2","article-title":"Revisiting the theoretical and methodological foundations of depression measurement","volume":"1","author":"Fried","year":"2022","journal-title":"Nat Rev Psychol"},{"key":"10.1016\/j.gde.2026.102511_sbref15","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41467-025-55831-z","article-title":"A data-driven latent variable approach to validating the research domain criteria framework","volume":"16","author":"Quah","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.gde.2026.102511_bib17","first-page":"533","article-title":"Meta-analysis of structural evidence for the Hierarchical Taxonomy of Psychopathology (HiTOP) model","volume":"53","author":"Ringwald","year":"2023","journal-title":"Psychol Med"},{"key":"10.1016\/j.gde.2026.102511_bib18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1186\/s12888-025-06960-8","article-title":"A framework for parsing psychopathological heterogeneity: initial application in a large-scale unselected community sample","volume":"25","author":"Wu","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib19","first-page":"218","article-title":"Research domain criteria: strengths, weaknesses, and potential alternatives for future psychiatric research","volume":"5","author":"Ross","year":"2019","journal-title":"Mol Neuropsychiatry"},{"key":"10.1016\/j.gde.2026.102511_sbref19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s44220-023-00057-5","article-title":"Precision behavioral phenotyping as a strategy for uncovering the biological correlates of psychopathology","volume":"1","author":"Tiego","year":"2023","journal-title":"Nat Ment Health"},{"key":"10.1016\/j.gde.2026.102511_bib21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/00220345211001850","article-title":"Science for the next century: deep phenotyping","volume":"100","author":"Wright","year":"2021","journal-title":"J Dent Res"},{"key":"10.1016\/j.gde.2026.102511_bib22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41593-020-0609-7","article-title":"Emerging phenotyping strategies will advance our understanding of psychiatric genetics","volume":"23","author":"Sanchez-Roige","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.gde.2026.102511_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/01622439251396978","article-title":"A postgenomic quilt: the turn to endophenotypes and deep phenotyping in human genetics","author":"Navon","year":"2025","journal-title":"Sci Technol Human Values"},{"key":"10.1016\/j.gde.2026.102511_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105541","article-title":"From smartphone data to clinically relevant predictions: a systematic review of digital phenotyping methods in depression","volume":"158","author":"Leaning","year":"2024","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.gde.2026.102511_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2020.103433","article-title":"Deep phenotyping: embracing complexity and temporality \u2014 towards scalability, portability, and interoperability","volume":"105","author":"Weng","year":"2020","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.gde.2026.102511_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.gde.2026.102511_bib27","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1038\/s41591-025-03790-9","article-title":"Deep phenotyping of health\u2013disease continuum in the Human Phenotype Project","volume":"31","author":"Reicher","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.gde.2026.102511_bib28","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/s41596-022-00696-5","article-title":"The normative modeling framework for computational psychiatry","volume":"17","author":"Rutherford","year":"2022","journal-title":"Nat Protoc"},{"key":"10.1016\/j.gde.2026.102511_bib29","first-page":"433","article-title":"Beyond lumping and splitting: a review of computational approaches for stratifying psychiatric disorders","volume":"1","author":"Marquand","year":"2016","journal-title":"Biological Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1016\/j.gde.2026.102511_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41398-023-02661-6","article-title":"Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies","volume":"13","author":"Worker","year":"2023","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib31","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41576-025-00843-0","article-title":"Genomics of schizophrenia, bipolar disorder and major depressive disorder","volume":"26","author":"Owen","year":"2025","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.gde.2026.102511_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.61373\/gp025r.0092","article-title":"Polygenic liability to C-reactive protein defines immunometabolic depression phenotypes and influences antidepressant therapeutic outcomes","volume":"1","author":"Serretti","year":"2025","journal-title":"Genom Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-020-0689-5","article-title":"Association of polygenic score for major depression with response to lithium in patients with bipolar disorder","volume":"26","author":"Amare","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2147\/NDT.S514514","article-title":"Transdiagnostic effects of schizophrenia polygenic scores on treatment outcomes in major psychiatric disorders","volume":"21","author":"Serretti","year":"2025","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.gde.2026.102511_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106284","article-title":"The promise of quantifying individual risk for brain disorders through normative modeling, a narrative review","volume":"176","author":"Fraza","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.gde.2026.102511_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41576-021-00409-w","article-title":"A new era in functional genomics screens","volume":"23","author":"Przybyla","year":"2022","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.gde.2026.102511_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41380-021-01201-2","article-title":"Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction","volume":"27","author":"Guan","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bpsgos.2022.07.005","article-title":"Novel functional genomics approaches bridging neuroscience and psychiatry","volume":"3","author":"Restrepo-Lozano","year":"2023","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"10.1016\/j.gde.2026.102511_bib39","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.biopsych.2025.10.004","article-title":"Identification and validation of immuno-inflammatory neuroimaging markers across major psychiatric disorders","volume":"99","author":"Tang","year":"2026","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41380-019-0479-0","article-title":"The complement system in schizophrenia: where are we now and what\u2019s next?","volume":"25","author":"Woo","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/science.1246949","article-title":"Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression","volume":"343","author":"Fairfax","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.gde.2026.102511_bib42","article-title":"Characterization of the genetic determinants of context-specific DNA methylation in primary monocytes","volume":"4","author":"Gilchrist","year":"2024","journal-title":"Cell Genom"},{"key":"10.1016\/j.gde.2026.102511_bib43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41467-017-00366-1","article-title":"Genetic regulatory effects modified by immune activation contribute to autoimmune disease associations","volume":"8","author":"Kim-Hellmuth","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.gde.2026.102511_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41576-022-00569-3","article-title":"Molecular mechanisms of environmental exposures and human disease","volume":"24","author":"Wu","year":"2023","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.gde.2026.102511_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jad.2024.10.126","article-title":"Genomics-driven integrative analysis highlights immune-related plasma proteins for psychiatric disorders","volume":"370","author":"Gong","year":"2025","journal-title":"J Affect Disord"},{"issue":"11","key":"10.1016\/j.gde.2026.102511_sbref45","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.biopsych.2025.05.021","article-title":"The future of immunotherapies for mental illness: a precision medicine perspective","volume":"99","author":"Wittenberg","year":"2025","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib47","doi-asserted-by":"crossref","first-page":"eadh9974","DOI":"10.1126\/scitranslmed.adh9974","article-title":"Transcriptomic sex differences in postmortem brain samples from patients with psychiatric disorders","volume":"16","author":"Xia","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.gde.2026.102511_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1291115","article-title":"Leveraging iPSC technology to assess neuro-immune interactions in neurological and psychiatric disorders","volume":"14","author":"Michalski","year":"2023","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib49","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/s41467-025-56569-4","article-title":"iPSCs and iPSC-derived cells as a model of human genetic and epigenetic variation","volume":"16","author":"Quaid","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.gde.2026.102511_bib50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41398-025-03529-7","article-title":"iPSC-derived cerebral organoids reveal mitochondrial, inflammatory and neuronal vulnerabilities in bipolar disorder","volume":"15","author":"El Soufi El Sabbagh","year":"2025","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1236553","article-title":"Functional genomics in stem cell models: considerations and applications","volume":"11","author":"Shevade","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.gde.2026.102511_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.830757","article-title":"Clozapine reverses dysfunction of glutamatergic neurons derived from clozapine-responsive schizophrenia patients","volume":"16","author":"Hribkova","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.gde.2026.102511_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor-alpha antagonist infliximab in treatment resistant depression: role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.gde.2026.102511_bib54","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psyneuen.2017.01.023","article-title":"Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial","volume":"78","author":"Jha","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.gde.2026.102511_sbref55","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1038\/s41380-024-02539-z","article-title":"Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?","volume":"29","author":"Chen","year":"2024","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41537-025-00650-w","article-title":"Immunosenescence-related T cell phenotypes, structural brain imaging, and cognitive impairment in patients with schizophrenia: a moderated mediation analysis","volume":"11","author":"Li","year":"2025","journal-title":"Schizophr"},{"key":"10.1016\/j.gde.2026.102511_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2026.106986","article-title":"Response to immune-based augmentation treatment for depression: a potential role of immunosenescence","volume":"5","author":"Van Assche","year":"2026","journal-title":"Neurosci Appl"},{"key":"10.1016\/j.gde.2026.102511_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-021-00368-1","article-title":"Immune targets for therapeutic development in depression: towards precision medicine","volume":"21","author":"Drevets","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.gde.2026.102511_sbref59","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-025-01165-w","article-title":"Biomarker-guided decision making in clinical drug development for neurodegenerative disorders","volume":"24","author":"Cummings","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.gde.2026.102511_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbi.2024.09.003","article-title":"Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo","volume":"123","author":"Sampson","year":"2025","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.gde.2026.102511_bib62","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1038\/s41467-022-30675-z","article-title":"The potential of polygenic scores to improve cost and efficiency of clinical trials","volume":"13","author":"Fahed","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.gde.2026.102511_bib63","doi-asserted-by":"crossref","first-page":"pyaf025","DOI":"10.1093\/ijnp\/pyaf025","article-title":"Moving toward precision and personalized treatment strategies in psychiatry","volume":"28","author":"Comai","year":"2025","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.gde.2026.102511_bib64","first-page":"193","article-title":"Precision medicine for psychosis: a revolution at the interface of psychiatry and neurology","volume":"19","author":"Keshavan","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.gde.2026.102511_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.gde.2026.102511_bib66","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2020.01.014","article-title":"Depression heterogeneity and its biological underpinnings: toward immunometabolic depression","volume":"88","author":"Milaneschi","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jamapsychiatry.2020.3436","article-title":"Dissecting the association between inflammation, metabolic dysregulation, and specific depressive symptoms: a genetic correlation and 2-Sample Mendelian randomization study","volume":"78","author":"Kappelmann","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41398-021-01348-0","article-title":"Mendelian randomization integrating GWAS and eQTL data revealed genes pleiotropically associated with major depressive disorder","volume":"11","author":"Yang","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.gde.2026.102511_bib69","doi-asserted-by":"crossref","first-page":"eaat8464","DOI":"10.1126\/science.aat8464","article-title":"Comprehensive functional genomic resource and integrative model for the human brain","volume":"362","author":"Wang","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.gde.2026.102511_bib70","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1080\/15592294.2021.1993607","article-title":"Spatiotemporal specificity of correlated DNA methylation and gene expression pairs across different human tissues and stages of brain development","volume":"17","author":"Wang","year":"2022","journal-title":"Epigenetics"},{"issue":"5","key":"10.1016\/j.gde.2026.102511_bib71","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00406-024-01944-3","article-title":"A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe","volume":"275","author":"Baune","year":"2024","journal-title":"Eur Arch Psychiatry Clin Neurosci"}],"container-title":["Current Opinion in Genetics & Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X2600078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X2600078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:21:13Z","timestamp":1788466873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X2600078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":71,"alternative-id":["S0959437X2600078X"],"URL":"https:\/\/doi.org\/10.1016\/j.gde.2026.102511","relation":{},"ISSN":["0959-437X"],"issn-type":[{"value":"0959-437X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional immunogenomics and deep clinical phenotyping to resolve the challenges of heterogeneity in mental disorders","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gde.2026.102511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102511"}}